Stocks to Watch: Intel, Deckers, Edwards Lifesciences, GenmabMorningStar·22 hours agoEW-1.42%GMAB-1.03%
Genmab, AbbVie clarify primary endpoints in Phase 3 EPCORE DLBCL-1 trialPUBT·1 day ago, 03:00 PMGMAB-1.03%ABBV+0.95%
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goalrttnews·Jul 10 at 11:15 AMABBV+0.95%VANI-7.91%
Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma | GMAB Stock NewsStockTitan·Jul 6 at 04:45 AMGMAB-1.03%
AbbVie (NYSE:ABBV) Sets New 12-Month High - Should You Buy?Market Beat·Jul 2 at 11:40 AMAPGE+1.00%ABBV+0.95%
Amazon To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga_article·Jul 2 at 06:41 AMGIS+1.35%GNRC-4.03%
Genmab/AbbVie Lymphoma Trial Meets Main Goal, Analyst Eyes Bigger Market Opportunitybenzinga_article·Jun 30 at 11:31 AMGMAB-1.03%ABBV+0.95%
